α2-Heremans Schmid glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunction

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue 4, 2002, Pages 305-310

  Ren, Jun ^a   Davidoff, Amy J ^b  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Contraction; GlucoseI; Tyrosine kinase; Ventricular myocyte

Indexed keywords

ALPHA2 HEREMANS SCHMID GLYCOPROTEIN; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; ALPHA2HS GLYCOPROTEIN; ENZYME INHIBITOR; PHOSPHOTYROSINE; PLASMA PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CARDIOMYOPATHY; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE METABOLISM; HEART MUSCLE CELL; HEART VENTRICLE; MALE; MUSCLE FIBER CONTRACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SIMULATION; TIME; ANIMAL; CELL CULTURE; DIABETIC ANGIOPATHY; DRUG ANTAGONISM; HEART; HEART CONTRACTION; METABOLISM; MUSCLE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PROTEINS; CARDIOMYOPATHIES; CELLS, CULTURED; DIABETIC ANGIOPATHIES; ENZYME INHIBITORS; GLUCOSE; HEART; HEART VENTRICLES; INSULIN; MALE; MUSCLE CELLS; MYOCARDIAL CONTRACTION; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036629513     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.299     Document Type: Article

References (33)

1. Ren J, Davidoff AJ. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 1997; 272: H148-H158.
2. Dutta K, Podolin DA, Davidson MB, Davidoff AJ. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 2001; 50: 1186-1192.
3. Abe T, Ohga Y, Tabayashi N, et al. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol 2002; 282: H138-H148.
4. Galderisi M, Anderson KM, Wilson PWF, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991; 68: 85-89.
5. 2+ exchanger activity in the diabetic heart. Cardiovasc Res 1997; 34: 129-136.
6. Zhong Y, Ahmed S, Grupp IL, Matlib MA. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 2001; 281: H1137-1147.
7. Davidoff AJ, Ren J. Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 1997; 272: H159-H167.
8. Ren J, Dominguez LJ, Sowers JR, Davidoff AJ. Troglitazone attenuates high glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes 1996; 45: 1822-1825.
9. Ren J, Gintant GA, Miller RE, Davidoff AJ. High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Physiol Heart Circ Physiol 1997; 273: H2876-H2883.
10. Amiri F, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB. Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells. J Biol Chem 1999; 274: 32 382-32 386.
11. Natarajan R, Scott S, Bai W, Yerneni KK, Nadler J. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions. Hypertension 1999; 33: 378-384.
12. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 1997; 46: 847-853.
13. Wang PH, Almahfouz A, Giorgino F, McCowen KC, Smith RJ. In vivo insulin signaling in the myocardium of streptozotocin-diabetic rats: opposite effects of diabetes on insulin stimulation of glycogen synthase and c-Fos. Endocrinology 1999; 140: 1141-1150.
14. Saltiel AS, Kahn CR. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001; 414: 799-806.
15. Kolter T, Uphues I Eckel J. Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol Endocrinol Metab 1997; 273: E59-E67.
16. Dziegielewska KM, Brown WM. Fetuin. Springer-Verlag Press: Heidelberg, 1995.
17. Srinivas PR, Deutsch DD, Mathews ST, Goustin AS, Leon MA, Grunberger G. Recombinant human α2-HS glycoprotein inhibits insulin-stimulated mitogenic pathway without affecting metabolic signalling in Chinese hamster ovary cells overexpressing the human insulin receptor. Cell Signal 1996; 8: 567-573.
18. Auberger P, Falquerho L, Contreres JO, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 1989; 58: 631-640.
19. Chen H, Srinivas PR, Cong L, Li Y, Grunberger G, Quon MJ. α2-Heremans Schmid glycoprotein inhibits insulin-stimulated Elk-1 phosphorylation, but not glucose transport, in rat adipose cells. Endocrinology 1998; 139: 4147-4154.
20. Jahnen-Dechent W, Schinke T, Trindl A, et al. Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 1997; 272: 31 496-31 503.
21. 2+] and pH in rat skinned cardiac myocytes. Am J Physiol Heart Circ Physiol 1995; 269: H1656-H1663.
22. 2+ handling in ventricular myocytes isolated from diabetic rats. Am J Physiol Heart Circ Physiol 1996; 270: H1529-H1537.
23. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease and nephropathy: an update. Hypertension 1995; 26: 869-879.
24. Barbagallo M, Shan J, Pang PK, Resnick LM. Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells. J Clin Invest 1995; 95: 763-767.
25. i of cardiac myocytes. Kidney Int 1998; 53: 1237-1243.
26. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-866.
27. Davidson MB, Ren J, Vlahos CJ, Davidoff AJ. PKCβ is elevated in high [glucose]-induced diabetic-like cardiomyopathy. Diabetes 2000; 49: A447.
28. Srivastava AK. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes. Int J Mol Med 2002; 9: 85-89.
29. Yuan SY, Ustinova EE, Wu MH, et al. Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circ Res 2000; 87: 412-417.
30. Ren J, Davidoff AJ. High glucose-induced abnormal relaxation in cultured adult cardiac myocytes is prevented by inhibiting PKC. J Mol Cell Cardiol 1997; 29: A185.
31. Mathews ST, Chellam N, Srinivas PR, et al. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000; 164: 87-98.
32. Ren J, Samson WK, Sowers JR. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 1999; 31: 2049-2061.
33. Lee WL, Chen JW, Ting CT, et al. Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. Endocrinology 1999; 140: 4831-4840.